DSpace JSPUI
DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets
Learn More
Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.12252/3941| Title: | Lupin signs an agreement with National Chemical Laboratory & DST |
| Keywords: | Continuous Purification Process Development Biosimilar Monoclonal Antibody Therapeutic Controlled Chromatography Processes Biopharmaceuticals Biologics Monoclonal Antibodies |
| Issue Date: | 8-Mar-2018 |
| Publisher: | Times of India |
| Description: | Pharma major Lupin has signed an agreement with CSIR-National Chemical Laboratory (CSIR-NCL, Pune) and Department of Science and Technology, (DST, Delhi) for conducting research on a continuous purification process development of a biosimilar monoclonal antibody therapeutic (mAb). Through this research collaboration, CSIR-NCL and Lupin would together work towards the development of a novel continuous purification process for manufacturing mAb therapeutics. |
| URI: | http://hdl.handle.net/20.500.12252/3941 |
| Appears in Collections: | Newspaper Clippings |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Lupin signs research pact with CSIR-NCL, Dept of Science &Tech - Times of India.pdf | Lupin collaborated with NCL & DST | 314.53 kB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.